MedTrace Logo

Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique

NCT03766672 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-08-21

No results posted yet for this study

Summary

In Martinique, about 33 new cases are diagnosed per year, with a high incidence rate of type 2 endometrial carcinoma which has a poor prognosis with few therapeutic options. Although targeted therapies are used in many types of cancer, they are still possible a minority of patients. In current practice, endometrial cancers do not benefit these therapies. Characterization of the molecular mechanisms involved in the genesis of type 2 endometrial carcinoma could help to identify biomarkers predictive of a response to targeted therapies. We propose to identify the genetic profile of type 2 endometrial carcinomas in Martinique.

Conditions

  • Endometrial Neoplasms

Interventions

DIAGNOSTIC_TEST

Intervention Arm

The intervention consists to the characterization of molecular mechanisms using to Next Generation Sequencing (NGS) technique.

Sponsors & Collaborators

  • Martinique Cancer Registry

    collaborator UNKNOWN

  • University Hospital Center of Martinique

    lead OTHER

Principal Investigators

  • Medhi JEAN-LAURENT, MD · CHU Martinique

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-22
Primary Completion
2021-11-22
Completion
2024-07-22

Countries

  • Martinique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03766672 on ClinicalTrials.gov